NEW YORK, Feb. 12 - Epoch Biosciences on Tuesday reported a surge in total revenues for the fourth quarter 2001 and a narrowed loss as strong sales outpaced a slight jump in operating costs.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.